Cytosorbents Crp (CTSO) is a Healthcare · Medical Devices company listed on NASDAQ. Price $5.75 (-0.17%), Market cap $0.03B, 52-week low–high $0.48 ~ $1.29.
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications. The company also develops DrugSorb-ATR antithrombotic removal system, an investigational device to
Financial statements, price targets, institutional (13F) holdings and related news for Cytosorbents Crp are updated in real time on BlackAll Trade.
Cytosorbents Crp trades at $5.75 (-0.17%). Real-time quotes and charts are available on BlackAll Trade.
Cytosorbents Crp has a market cap of about $0.03B.
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and international